Ein Mann mittleren Alters in einem dunklen Nadelstreifenanzug, einem hellblauen Hemd und einer gestreiften Krawatte lächelt in die Kamera eines modernen Anwaltsbüros.

Michael J. Tuteur

Partner/Ruhestand

Michael J. Tuteur

Partner/Ruhestand

Mike Tuteur has spent nearly 40 years successfully trying cases and arguing appeals in both civil and criminal courts around the country. He is sought after for his seasoned judgment, trial experience, and litigation victories. Mike served as chair of the firm’s national Litigation Department from 2009 to 2015, as well as chair of its Commercial Litigation Practice. He is a partner in the Government Enforcement Defense & Investigation Practice and a former member of the firm’s national Management Committee.

Mike represents a broad range of clients, with a particular focus on health care litigation, False Claims Act defense, government and internal investigations, and scientific and research misconduct. He has recently been involved in FCA matters involving Medicare Advantage as well as assisting various health care entities, including “High Impact Target” hospitals, avoiding FCA liability in connection with the CARES Act, the Paycheck Protection Program, and the Health Care Enhancement Act.

Mike’s extensive experience includes ERISA and RICO class actions, False Claims Act (FCA) litigation, and the defense of both organizations and individuals in Justice Department and SEC investigations. He is particularly skilled in investigating and defending academic institutions in connection with claims of scientific misconduct and research misconduct. And he was named “Lawyer of the Year” in Boston for Bet-the-Company Litigation in both 2018 and 2020 by Best Lawyers in America.

Earlier in his career, Mike served as an Assistant U.S. Attorney in the Major Crimes and Organized Crime Strike Force units of the U.S. Attorney’s office in Boston. Between his prosecutorial experience and his private practice, Mike has tried more than 20 cases to decision. He has also argued nearly 20 appeals in state and federal appellate courts across the country.

Mike has been appointed a Special Assistant Attorney General on several occasions, including four appointments to represent Massachusetts Govs. William F. Weld and A. Paul Cellucci in constitutional cases involving the scope and effect of the governor’s veto power. A U.S. District Judge appointed Mike to investigate allegations of document destruction and attorney misconduct. Mike also served as an expert witness to the Royal Courts of Justice in London to give opinion evidence on the application of U.S. law to the Latin American syndicated debt market.

“He’s a terrific, standout lawyer and very intelligent,” according to Chambers & Partners, USA. “His experience, his writing and his judgment are all strong.”

Mike received his A.B. from Harvard College, summa cum laude, and his J.D. from Harvard Law School, magna cum laude. He now serves as a trial adviser at Harvard Law School’s Trial Advocacy Workshop and judges its Ames Moot Court program. He also has taught at the Harvard School of Public Health’s Continuing Education Program on Corporate Compliance and is a frequent writer and speaker on civil and criminal jurisprudence, with a special emphasis on the law of research and scientific misconduct.

Mike has devoted significant time to litigating special education cases on a pro bono basis. He has helped make new law in the First Circuit on behalf of special needs families who have been forced by financial constraints to leave their place of residence. For his pro bono work, the Massachusetts Supreme Judicial Court’s Standing Committee on Pro Bono Legal Services awarded Mike its Certificate of Recognition in 2007.

Mike is a member and former chair of the Advisory Board of the Smithsonian Astrophysical Observatory, a component of the Center for Astrophysics | Harvard & Smithsonian and serves on the Smithsonian New England Regional Council.

Auszeichnungen und Anerkennungen

  • Named Best Lawyers® 2018 and 2020 Bet-the-Company Litigation “Lawyer of the Year” in Boston
  • Von seinen Kollegen ausgewählt für die Aufnahme in The Best Lawyers in America® auf den Gebieten der:
    • Bet-the-Company Litigation (2010-2024)
    • Commercial Litigation (2007, 2010-2024)
    • Criminal Defense: White-Collar (2007, 2011, 2013-2023)
    • Health Care Law (2018-2023)
  • Recognized in Chambers USA: Amerikas führende Anwälte für Wirtschaft in the practice areas of:
    • Litigation: General Commercial (2004-2024)
    • Litigation: White-Collar Crime & Government Investigations (2004-2015)
  • Top 100 Massachusetts Super Lawyers® (2004-present)

Präsentationen und Veröffentlichungen

  • Co-author, “The 25th Anniversary of the Business Litigation Session: A Look Back,” Boston Bar Journal (Fall 2024)
  • Co-Autor, "Dezentrale klinische Studien: Research Misconduct Risks & How to Avoid Them," Health Care Law Today (30. September 2024)
  • Co-author, “Medicare Advantage: A Circuit Court Addresses What is (or is not) Material in False Claims Act Cases,” Health Care Law Today (September 18, 2024)
  • Co-author, “Business Litigation Session 2023 Year in Review,” Mass. Lawyers Weekly.
  • Author, “‘Let’s Talk Compliance’: Medicare Advantage: Compliance Issues and Enforcement” Health Care Law Today (March 12, 2024)
  • Co-author, “HRSA Uninsured Program COVID-19 Services: What Were the Standards to Determine Uninsured Status?” The National Law Review (August 17, 2023)
  • Speaker, “Supreme Court’s EPA Ruling Jeopardizes Healthcare Regulations,” Modern Healthcare (July 12, 2022)
  • Co-author, “Massachusetts Business Litigation Session,” American Bar Association Recent Developments in Business Courts 2022 (February 2, 2022)
  • Co-author, “Protecting Your Institution from False Claims Act Allegations After Receipt of CARES Act Funding,” American Health Law Association (November 11, 2020)
  • Co-author, “Year in review: the Business Litigation Session, 2019,” Massachusetts Lawyers Weekly (January 2020)
  • Co-author, “Provisional Remedies,” Practical Law (October 2019)
  • Co-author, “Commencing an Action: Massachusetts,” Practical Law (April 2019)
  • Panelist/speaker: The Business Litigation Session: Year in Review 2018, presented by Social Law Library and Mass. Lawyers Weekly (January 2019)
  • Co-author, “That ‘Hot’ Research Project May Land Your Lab in Hot Water,” Compliance Today (November 2018)
  • Co-author, “Responding to a Complaint: Massachusetts,” Practical Law (November 2018)
  • Co-author, “Q&A Litigation Overview: Massachusetts,” Practical Law (October 2018)
  • Panelist, “Government Sponsored Research, Research Integrity, and the False Claims Act,” ABA National Institute to the Civil False Claims Act (June 2018)
  • Panelist, “Understanding the Difference Between Scientific Research, Misconduct and Fraud,” ACC (June 19, 2018)
  • Co-author, “Scientific research misconduct vs. fraud: How to tell the difference.” Compliance Today (May 2018)
  • Co-author, “The Business Litigation Session Year in Review,” Massachusetts Lawyers Weekly (January 4, 2018)
  • Speaker, “Exhibit (Facebook): The Impact of Social Media on Civil Litigation,” Boston Bar Association (October 6, 2016)
  • Speaker, “Use and Misuse of ERISA in Out-of-Network Litigation,” Blue Cross Blue Shield Summit (May 17, 2016)
  • Speaker, “World Recognition of Distinguished General Counsel,” The Directors Roundtable (February 2, 2014)
2. Juli 2025 Pro Bono

Foley sichert Pro-Bono-Sieg, der den Abschluss eines Sonderschülers ermöglicht

Foley & Lardner LLP hat einen Pro-Bono-Sieg errungen, indem sie für einen Sonderschüler entscheidende Bildungsunterstützung erwirkt hat. Infolge des Eingreifens von Foley und des sieben Jahre zuvor eingeleiteten Rechtsstreits konnte der Mandant vor kurzem seinen Highschool-Abschluss machen und an der Aufnahmezeremonie teilnehmen.
Ein Satz Reagenzgläser mit blauer Flüssigkeit, angeordnet in einem weißen Gestell auf einem Labortisch, umgeben von anderen Glasgeräten, erinnert an die Präzision, die oft in Kanzleien für geistiges Eigentumsrecht zu finden ist.
September 30, 2024 Health Care Law Today

Dezentrale klinische Studien: Risiken von wissenschaftlichem Fehlverhalten und wie man sie vermeidet

Die COVID-19-Pandemie erforderte eine Anpassung des Gesundheitswesens an die Fernversorgung von Patienten, einschließlich derjenigen, die an klinischen Studien teilnehmen, und während der Pandemie verbreitete sich die Verwendung dezentralisierter klinischer Studien.
September 24, 2024 Health Care Law Today

Research Misconduct: ORI Issues Final Rule with Modernized and Streamlined Regulations

On September 17, 2024, the Office of Research Integrity (ORI) issued a final rule adopting changes to federal regulations governing research misconduct involving federally funded research (Final Rule).
Nahaufnahme einer Büroklammer, die eine Medicare-Karte und Dokumente zusammenhält, wobei „Medicare“ deutlich zu sehen ist – ein Bild, das man oft in einer Wirtschaftskanzlei oder bei Anwälten in Chicago sieht, die mit sensiblen Mandanteninformationen umgehen.
September 18, 2024 Health Care Law Today

Medicare Advantage: Ein Berufungsgericht befasst sich mit der Frage, was in Fällen nach dem False Claims Act wesentlich ist (und was nicht)

Am 13. September 2024 veröffentlichte das Berufungsgericht der Vereinigten Staaten für den achten Gerichtsbezirk seine mit Spannung erwartete Entscheidung in der Rechtssache United States ex rel. Holt v. Medicare Medicaid Advisors und bestätigte damit die Abweisung einer Medicare-Advantage-Klage durch den Western District of Missouri – ein Sieg für die Akteure im Bereich Managed Care, insbesondere für Versicherungsgesellschaften, Versicherungsmakler und Versicherungsmarketingorganisationen.
6. Juni 2024 Presseveröffentlichungen

Foley erreicht Spitzenplatzierungen bei Chambers USA 2024

Foley & Lardner LLP freut sich bekannt zu geben, dass sie in der Ausgabe 2024 von Chambers USA, America's Leading Lawyers for Business, erneut von Chambers & Partners als eine der führenden Anwaltskanzleien des Landes anerkannt wird.
Ein Stethoskop liegt auf einem Blatt Papier mit blauen Balken- und Liniendiagrammen, was auf einen Zusammenhang zwischen der Analyse von Gesundheitsdaten und der Unterstützung bei Rechtsstreitigkeiten in Anwaltskanzleien hindeutet.
March 12, 2024 Health Care Law Today

„Let’s Talk Compliance“: Medicare Advantage: Compliance-Fragen und Durchsetzung

Während der dritten Sitzung der Reihe „Let’s Talk Compliance“ sprachen Valerie Rock, Geschäftsführerin von PYA, und Michael Tuteur, Partner bei Foley and Lardner, über die sich wandelnde Landschaft im Zusammenhang mit der staatlichen Kontrolle und Aufsicht über Medicare Advantage (MA)-Pläne und deren Zahlungen.